| Trial of Amgen drug was halted Los Angeles Times - The study of an anemia treatment found higher tumor risks, the firm says four months later. By Daniel Costello, Times Staff Writer. UPDATE 1-New Aranesp safety concerns seen in cancer trial Amgen stock down as study discussed |